| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/23/2008 | CA2375679C Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 09/23/2008 | CA2336833C Remedy with antidepressant effects |
| 09/23/2008 | CA2333323C Method and compositions for treatment of cancers |
| 09/23/2008 | CA2310055C New urethanes, the thio and dithio analogues thereof,the salts thereof, pharmaceutical compositions containing these compounds and their use as well as process for preparing them |
| 09/23/2008 | CA2210109C Method to prevent transplant rejection |
| 09/18/2008 | WO2008111597A1 Remedy for chemotherapy-resistant cancer containing hla class i-recognizing antibody as the active ingredient and use of the same |
| 09/18/2008 | WO2008111520A1 Gene related to life extension and use thereof |
| 09/18/2008 | WO2008111441A1 Pharmaceutical composition |
| 09/18/2008 | WO2008111296A1 Pharmaceutical agent for prevention and treatment of skin disease induced by accelerated keratinization |
| 09/18/2008 | WO2008110815A1 Polyaphron topical composition with vitamin d and corticosteroid |
| 09/18/2008 | WO2008110491A2 Chemotherapy of neoplastic diseases using combinations of rapamycin and compounds modulating mtor pathway alone or in combination with heat |
| 09/18/2008 | WO2008110006A1 Biomarkers of prostate cancer and uses thereof |
| 09/18/2008 | WO2008109972A1 Homeopathic medicament useful for immunomodulation |
| 09/18/2008 | WO2008091620A3 Combination therapy comprising romidepsin and i.a. bortezomib |
| 09/18/2008 | WO2008087441A3 An influenza prevention and treatment composition |
| 09/18/2008 | WO2008059014A3 Antituberculosis agents with alkylidene or alkyl side chain |
| 09/18/2008 | WO2008049842A3 Egfr kinase inhibitor combinations for the treatment of respiratory and gastrointestinal disorders |
| 09/18/2008 | WO2008045920A3 Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses |
| 09/18/2008 | WO2008031831A3 Pharmaceutical compositions comprising combinations of an ampa/kainate antagonistic compound and an inhibitor of a multidrug resistance protein |
| 09/18/2008 | WO2008020039A3 2,5-dihydroxybenzene compounds for treating cancers and hematological dyscrasias |
| 09/18/2008 | US20080227845 Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination |
| 09/18/2008 | US20080227767 Methods and compounds for inhibiting amyloid deposits |
| 09/18/2008 | US20080227764 E.g., 3,-30-pregnanediones or 11,20-pregnanedioles; optionally in association with one or more other analgesic compounds such as opioids; does not result in overt sedation |
| 09/18/2008 | US20080227761 Ameliorating a Th1 mediated immune pathology such as multiple sclerosis by raaising the serum concentration of estrogen to 30-1000 pg/ml by administering, e.g., 17-beta-estradiol, estriol or estrone; and administering a glatiramer acetate |
| 09/18/2008 | US20080227758 Nitric Oxide Releasing Prodrugs of Diaryl-2-(5h)-Furanones as Cyclooxygenase-2 Inhibitors |
| 09/18/2008 | US20080227695 reduced expression and/or function of Dlg (discs large) is an important factor for tumor formation; measuring the expression and/or function of Dlg |
| 09/18/2008 | US20080227135 Autoimmune Conditions and NADPH Oxidase Defects |
| 09/18/2008 | US20080227129 Using multimeric ubiquitin fusion protein as an enzyme activity indicator; destruction of reporter demonstrate enhanced enzyme activity |
| 09/18/2008 | US20080227127 Human NK3-Related Prostate Specific Gene-1 |
| 09/18/2008 | US20080226751 Wound healing agents; skin ulcers; post-operative trauma or burns; allows passage of nitric oxide to skin; ischaemia, Raynaud's phenomenon |
| 09/18/2008 | US20080226732 Nanoparticulate compositions of angiogenesis inhibitors |
| 09/18/2008 | US20080226695 Water degradation; controlled drying; self-supporting edible film; uniform distribution; mixing water soluble polymer with water and active material; deaeration |
| 09/18/2008 | US20080226687 Drug delivery and method having coated microprojections incorporating vasoconstrictors |
| 09/18/2008 | US20080226674 Anticancer drugs encapsulated in and mixed with envelop protein virus vector; intensify immunology response in animals |
| 09/18/2008 | US20080226654 Uses of mammalian cytokine; related reagents |
| 09/18/2008 | US20080226620 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226614 Eukaryotic Based Synergistic Formulation for Gastro-Intestinal Disorders |
| 09/18/2008 | US20080226613 Using chronic inflammation as evaluative tool in predicting and detecting metastatic cancer |
| 09/18/2008 | US20080226564 Bioactive material in perforated microstructure; propellant suspension; mixture of bronchodilator and antiinflammatory agent |
| 09/18/2008 | US20080226556 Using macrophages;milk fat globulins; epidermal growth factor mutants |
| 09/18/2008 | US20080226554 Polynucleotides encoding markers |
| 09/18/2008 | US20080226498 analysis apparatus comprising a holder for liquid samples, multiwell plates, conveyors for transferring the liquid sample from the holder to the plates and a module configured to control processing of the liquid sample; high speed screening of samples |
| 09/18/2008 | CA2680556A1 Biomarkers of prostate cancer and uses thereof |
| 09/18/2008 | CA2680405A1 Polyaphron topical composition with vitamin d and corticosteroid |
| 09/18/2008 | CA2680280A1 Remedy for chemotherapy-resistant cancer containing hla class i-recognizing antibody as the active ingredient and use of the same |
| 09/18/2008 | CA2680122A1 Pharmaceutical composition |
| 09/18/2008 | CA2679975A1 Therapy for hyperglycemia, related disorders and erectile dysfunction |
| 09/17/2008 | EP1970076A1 Pharmaceutical composition for application to nail |
| 09/17/2008 | EP1970075A1 THERAPEUTIC AGENT FOR NEUROBLASTOMA TARGETING ARID3b |
| 09/17/2008 | EP1970072A1 Use of GLP-2 peptides for the treatment of hyperparathyroidism |
| 09/17/2008 | EP1970063A1 Therapeutic agent for diabetes |
| 09/17/2008 | EP1970059A1 Medication with Dobesilat-Calcium for treatment and prophylaxis of tendon disease |
| 09/17/2008 | EP1970058A1 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 09/17/2008 | EP1969008A2 Antibodies against interleukin-22 binding protein and its uses for the treatment of metabolic disorders |
| 09/17/2008 | EP1968705A1 Pharmaceutical combination of a pde-5 inhibitor and a 5-alpha reductase inhibitor |
| 09/17/2008 | EP1968627A2 Compositions for disrupting and inhibiting reconstitution of wound biofilm |
| 09/17/2008 | EP1968545A2 Medicament for topical use |
| 09/17/2008 | EP1968544A2 Drug delivery system for bioadhesion to a vulvovaginal surface |
| 09/17/2008 | EP1968543A2 Composition and method of use thereof |
| 09/17/2008 | EP1968539A2 Abuse resistant transmucosal drug delivery device |
| 09/17/2008 | EP1896042A4 Methods and reagents for the treatment of inflammatory disorders |
| 09/17/2008 | EP1588162B1 Hsc70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
| 09/17/2008 | EP1490067B1 Use of tyrosine kinase inhibitors for treating substance use disorders |
| 09/17/2008 | EP1463525B1 Compositions and methods for the diagnosis and treatment of tumor |
| 09/17/2008 | EP1284999B1 Repair of nerve damage |
| 09/17/2008 | EP1253941B1 Pre-transplant accommodated organs resistant to anti-donor immunity |
| 09/17/2008 | EP1233670B1 Nitric oxide donors for inducing neurogenesis |
| 09/17/2008 | EP1202736B1 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 09/17/2008 | CN101267838A Use of a DPP-IV inhibitor to reduce hypoglycemic events |
| 09/17/2008 | CN101267837A Compositions for treatment of systemic mastocytosis |
| 09/17/2008 | CN101267836A Single dose use of CD20-specific binding molecules |
| 09/17/2008 | CN101267807A Composition comprising a nsaid and paracetamol |
| 09/17/2008 | CN101265285A Immunostimulatory nucleic acid molecules |
| 09/17/2008 | CN101264329A Medicinal composition for diminishing inflammation and ease pain and preparation and use thereof |
| 09/17/2008 | CN101264328A Anticancer sustained-release gel injection containing stines medicine |
| 09/17/2008 | CN101264324A Blocking immune response to a foreign antigen using an antagonist which binds to CD20. |
| 09/17/2008 | CN101264095A Application of polydatin in preventing and controlling obesity and relieving insulin resistance |
| 09/17/2008 | CN101264073A Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 09/17/2008 | CN101264072A Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 09/17/2008 | CN101264057A PH-sensitive long circulating liposomes composition and preparation thereof |
| 09/17/2008 | CN101264052A Compound anticancer sustained-release agent containing clofarabine |
| 09/17/2008 | CN100418578C Medication composition of plant estrogens for treating colpitis |
| 09/17/2008 | CN100418533C Pharmaceutical combinations of cox-2 inhibitors and opiates |
| 09/17/2008 | CN100418531C Therapeutic agents comprising an anti-angiogenic agent in combination with an src-inhibitor and their therapeutic use |
| 09/17/2008 | CN100418527C Improved pharmaceutical formulations |
| 09/17/2008 | CN100418526C Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension |
| 09/16/2008 | US7425623 Binding to surface of tumor cell; bacteriophage separation; in situ diagnosis |
| 09/16/2008 | US7425610 Expression vector comprising nucleotide sequences coding novel receptor protein for use in prevention and treatment of cell proliferative and autoimmune disorders |
| 09/16/2008 | US7425573 Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration |
| 09/16/2008 | US7425571 synergistic admnistration of a weight-loss promoting anticonvulsant and a norepinephrine or dopamine agonist; hypotensive, antidiabetic, anticholesterol agents |
| 09/16/2008 | US7425550 Lactam glycogen phosphorylase inhibitors and method of use |
| 09/16/2008 | US7425535 Therapeutic pore-forming peptides |
| 09/16/2008 | US7425532 Use of alanyl aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/16/2008 | US7425343 Process and composition for controlling fecal hair excretion and trichobezoar formation |
| 09/16/2008 | US7425336 Canine influenza vaccines |
| 09/16/2008 | US7425332 administering a mixture of polypeptides consisting of glutamic acid, tyrosine, alanine and lysine, that bind to antigen presenting cells, human leukocyte antigens and major histocompatibility complex molecules, for the treatment of autoimmune diseases |
| 09/16/2008 | US7425292 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 09/16/2008 | CA2505128C Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 09/16/2008 | CA2480429C Novel therapeutical use of agonist ligands specific to g2a receptor |
| 09/16/2008 | CA2409748C Soluble ctla4 mutant molecules and uses thereof |